Blue Belt Robotic Surgery Buy Is A 'Must-Have,' Says Smith & Nephew

S&N will pay $275 million to buy Blue Belt, which is still in the red and is expected to generate only $19 million in revenue for 2015 through sales of its Navio surgical system. The firm's sales team has been vocal in support of acquiring the technology, executives said.

Smith & Nephew PLC is paying a significant premium to acquire Blue Belt Technologies Inc.and get a foothold in the growing orthopedic robotics surgery market.

Under the terms of the agreement, S&N will pay $275 million – using existing debt facilities – to buy Blue Belt, which is still in the red and is expected to generate only $19 million in revenue for 2015 through sales of its Navio surgical system

More from Archive

More from Medtech Insight

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By 

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.